For many men, a prostate cancer scare starts with one number. A PSA result comes back high, and ...

The Stockholm3 model combines PSA, plasma protein biomarkers, polygenic risk, and clinical factors for prostate cancer screening.

A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...

The understanding of prostate cancer has significantly evolved in the past 15 years. However, many people—including primary care providers—may not be aware of the current guidelines for prostate ...

Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...

Annual check-ups save lives by detecting prostate issues early, yet many men avoid these crucial tests due to fear or misconceptions. Prostate health significantly impacts overall well-being, making ...

Blood-based biomarker test had similar false-positive rate as PSA, while reducing false ne ...

Hormone therapy initiation depends on disease extent; some agents avoid testosterone flare, allowing ADT without Casodex in certain cases. Active surveillance is increasingly chosen for favorable ...

A new study suggests the investigational Stockholm3 blood test may improve the early detection of aggressive prostate cancer ...

The Korean Urological Oncology Society (President Jeong Byeong-chang) held a press conference at the Korea Press Center on the 16th and announced the '2026 ...